Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) is a leader in KLH production and sales of this important biomedical ingredient. A micro-cap stock, with sales in North America and Europe, the company plans to continue to grow revenues internationally. Stellar Biotechnologies’ customers work to advance personalized medicine, develop novel therapeutics and vaccines, molecular diagnostics and veterinary research and outcomes. For more than 10 years, the company has tapped the dynamism of scientific discovery and innovation to advance medicine. Stellar anticipates robust growth into 2015 and beyond. We have an unshakeable commitment to our mission and values, and we expect to build shareholder value while also helping patients with serious, unmet medical needs.
